Baret News – Lifestyle

Author: CorMedix, Inc.

CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transplantation Patients

April 27, 2026
CorMedix to Participate in Needham Virtual Healthcare Conference

April 7, 2026
CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

March 5, 2026